Wendy DiCicco joins EyePoint Pharmaceuticals board

EyePoint Pharmaceuticals, a specialty biopharmaceutical company, has appointed Wendy DiCicco to the company’s audit committee and board of directors.

Advertisement

Ms. DiCicco will support the company’s efforts to launch its ophthalmic products. Previously, Ms. DiCicco was chief operating and financial officer of Centinel Spine, a distributor of spinal implants.

She also serves on the board of directors for Carmell Therapeutics, a biotechnology company. Ms. DiCicco is a board leadership and corporate governance fellow of the National Association of Corporate Directors.

More articles on supply chain:
ASC supply chain tip of the day: Play ‘The Price is Right’
Ospitek’s new AI-enabled platform automates ASC tasks
ASC supply chain tip of the day: Limit storage locations

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.